All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Originally posted by @nikkiryan on Instagram · 55s|Watch on Instagram
Full video transcriptClick to expand

Auto-generated transcript of @nikkiryan's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.

  1. 0:00Hey Chate, so where am I at with it all? I have been using the patches and I was taking
  2. 0:07the progesterone orally and I just didn't feel like it was having the best impact on my body.
  3. 0:14I was getting severe bloating and when I say severe I literally look like I was 6 months
  4. 0:19pregnant and I just was feeling tired all the time and my mood went quite low and obviously
  5. 0:26all of it is designed to make you feel better and I just wasn't really feeling better so
  6. 0:31after a chat with my absolutely incredible doctor I decided to go down the route of the
  7. 0:37marina coil instead of having the progesterone orally I'm going to get the coil and just see
  8. 0:42how I get on with it and go from there. So I'm just interested in your experience with
  9. 0:49HRT so far too and just yeah let's just open up a conversation about it.

@nikkiryan's HRT perimenopause update needs more context

Nikki Ryan | 40+ Style & Glow Up

Instagram creator

77.8K viewsView on Instagram

Quick answer

The creator describes switching from oral micronized progesterone to a levonorgestrel-releasing IUD (Mirena) as the progestogen component of her HRT regimen, while continuing transdermal estrogen patches. This is a recognized clinical strategy to reduce systemic progestogenic side effects such as bloating, mood depression, and fatigue in perimenopausal women who do not tolerate oral progesterone. The Mirena is used off-label in this context in many countries, but is supported by British Menopause Society guidance and published evidence for endometrial protection.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

TRT social video fact-checksMedical claim reviewProvider discussion

Evidence signal

Source-backed review

Regulatory reality

Access rules depend on the compound and patient situation

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 7 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For @nikkiryan's HRT perimenopause update needs more context, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Provider decision path

Use local research to choose a safer review path

Direct answer

@nikkiryan's HRT perimenopause update needs more context is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.

Evidence check

Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.

Safety check

Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.

Next step

When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.

Claim path

Keep researching this testosterone and trt video claims cluster

Best for searchers turning TRT social claims into a safer lab-backed provider discussion.

Page-specific review note

What this exact clip is really saying

This FormBlends review is specific to "@nikkiryan's HRT perimenopause update needs more context" from Nikki Ryan | 40+ Style & Glow Up. We read the clip as a TRT social video fact-checks claim about Testosterone, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: The creator describes switching from oral micronized progesterone to a levonorgestrel-releasing IUD (Mirena) as the progestogen component of her HRT regimen, while continuing transdermal estrogen patches.

The reason this review is not generic is the source wording and the canonical claim label "trt hrt perimenopause i have gone to share this a few times the." In this clip, the useful excerpt is: "Hey Chate, so where am I at with it all?" That wording changes the review because it points to Testosterone evidence, safety, and patient-fit context, not a one-size-fits-all protocol.

The source trail for this page is checked against Cardiovascular Safety of Testosterone-Replacement Therapy (2023), Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline (2010), and Functional testosterone deficiency in aging men: Clinical impact, diagnostic pathways, and treatment strategies (2026), plus the creator's own wording. Testosterone decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.

The Mirena IUD delivers levonorgestrel locally to the uterine lining with very low systemic absorption, making it a lower-side-effect alternative progestogen for women on systemic estrogen HRT.
People who land here are usually trying to understand whether the Testosterone claim is evidence-backed, safe, and relevant to their own situation.
The strongest next step is to compare the claim with FormBlends' Testosterone guide, evidence notes, and provider review path before acting.

Claim verdict

The useful answer behind this video

This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.

Claim being checked

The creator describes switching from oral micronized progesterone to a levonorgestrel-releasing IUD (Mirena) as the progestogen component of her HRT regimen, while continuing transdermal estrogen patches.

FormBlends verdict

Testosterone evidence, safety, and patient-fit context

Evidence strength

Source-backed review with clinical or regulatory citations.

Patient-safe next step

Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • The creator describes switching from oral micronized progesterone to a levonorgestrel-releasing IUD (Mirena) as the progestogen component of her HRT regimen, while continuing transdermal estrogen patches. This is a recognized clinical strategy to reduce systemic progestogenic side effects such as bloating, mood depression, and fatigue in perimenopausal women who do not tolerate oral progesterone. The Mirena is used off-label in this context in many countries, but is supported by British Menopause Society guidance and published evidence for endometrial protection.
  • Oral progesterone undergoes first-pass liver metabolism producing neuroactive steroids, which cause bloating, sedation, and mood changes in a clinically significant subset of women (Stanczyk et al., 2015, Climacteric).
  • The Mirena IUD delivers levonorgestrel locally to the uterine lining with very low systemic absorption, making it a lower-side-effect alternative progestogen for women on systemic estrogen HRT.

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • Compound access, legal status, and product quality still need a separate safety check.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.

Start provider review

What You'll Learn

  • Oral progesterone undergoes first-pass liver metabolism producing neuroactive steroids, which cause bloating, sedation, and mood changes in a clinically significant subset of women (Stanczyk et al., 2015, Climacteric).
  • The Mirena IUD delivers levonorgestrel locally to the uterine lining with very low systemic absorption, making it a lower-side-effect alternative progestogen for women on systemic estrogen HRT.
  • Hamoda et al. (2022, Post Reproductive Health) confirmed Mirena provides effective endometrial protection for up to five years when combined with systemic estrogen therapy.
  • The Mirena is used off-label as a progestogen in HRT in many countries, including the UK, meaning it is not specifically licensed for this purpose, though it is recognized in British Menopause Society guidance.
  • Timing oral progesterone at night with food can reduce side effects for some women before a full switch to another delivery method is considered.
  • Transdermal progesterone cream is another alternative but has weaker evidence for endometrial protection compared to the Mirena or oral progesterone.
  • Bloating and fatigue in perimenopause are not always attributable to progesterone alone. Thyroid dysfunction and sleep disruption from perimenopause itself can produce overlapping symptoms.

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.

What did @nikkiryan actually say?

Nikki Ryan shared a candid update on her HRT journey, explaining that the estrogen patches combined with oral progesterone were not working for her. She described "severe bloating" that made her look "6 months pregnant," persistent fatigue, and low mood. After consulting her doctor, she switched from oral progesterone to a Mirena IUD (the hormonal coil) as her progestogen delivery method, keeping the estrogen patches. She framed this as a personal experience, not advice, and invited others to share their own HRT stories.

This is a genuinely common clinical scenario, and she described it accurately without overclaiming. She did not suggest this is a universal solution. Credit where it is due: she explicitly named her doctor as the decision-maker here.

Does the science back this up?

Yes, largely. The side effects she described are consistent with what the literature shows for oral micronized progesterone. The Mirena coil as an alternative progestogen delivery route in perimenopause is a recognized and evidence-supported option.

Oral progesterone undergoes first-pass liver metabolism, which produces metabolites (including allopregnanolone) that can cause mood disturbance, bloating, and sedation in some women. A 2015 study by Stanczyk et al. in Climacteric documented that these metabolites vary widely between individuals, which helps explain why some women tolerate oral progesterone poorly while others do not. The Mirena IUD delivers levonorgestrel locally to the uterine lining, producing minimal systemic absorption, which means far fewer systemic progestogenic side effects. Simon et al. (2006, Menopause) confirmed the Mirena's efficacy as the progestogen component of HRT for endometrial protection. This is also consistent with guidance from the British Menopause Society, which recognizes the Mirena as an off-label but clinically accepted progestogen option in HRT regimens.

What did they get wrong (or right)?

Nikki got the key facts right. The side effects she attributed to oral progesterone, specifically bloating, fatigue, and low mood, are biologically plausible and well-documented in clinical literature. She did not misattribute these to the estrogen patch, which is an easy mistake people make online.

One thing worth flagging: she did not specify whether her patches are estradiol-only, which matters clinically because the progestogen component is only necessary if she has a uterus. Given she is moving to a Mirena for endometrial protection, we can reasonably assume she does. This is a gap in the video's context, not a factual error on her part. She also did not mention that the Mirena is not licensed specifically as an HRT progestogen in all countries, including the UK, meaning it is prescribed off-label in this context. That nuance would have been useful for her audience to know, even briefly. Still, she was accurate in saying the move was made to address her symptoms, not to abandon HRT altogether.

What should you actually know?

If you are on HRT and feeling worse rather than better, that is worth taking seriously. The "it takes time to adjust" framing is sometimes valid, but persistent bloating, fatigue, and low mood after starting oral progesterone can signal a genuine intolerance rather than a temporary adjustment phase.

The Mirena coil as a progestogen source in HRT is a legitimate clinical option, but it is not right for everyone. It requires insertion by a clinician, carries a small risk of expulsion, and some women experience spotting for several months after placement. It does not replace estrogen, so patches, gels, or sprays still need to be used alongside it. A 2022 review by Hamoda et al. in Post Reproductive Health noted that the Mirena provides effective endometrial protection for up to five years when used with systemic estrogen. Transdermal progestogens (creams or gels) are another alternative some clinicians use, though evidence for endometrial protection from transdermal progesterone alone is weaker. The bottom line: if oral progesterone is making you feel awful, you have options, and Nikki is right to say this conversation is worth having openly.

Is there anything missing from the conversation?

A few things did not make it into the video that would add useful context for her 77,000-plus viewers. First, not all bloating and fatigue on HRT is progesterone's fault. Thyroid changes, gut issues, and sleep disruption from perimenopause itself can all contribute. Second, the type of progesterone matters. Utrogestan (micronized progesterone) is body-identical, but it still causes first-pass metabolite issues in sensitive individuals. Synthetic progestogens behave differently again. Third, timing of oral progesterone (taking it at night, with food) can reduce side effects for some women without needing to switch delivery method entirely. These are not criticisms of Nikki's choice, which sounds clinically well-supported. They are gaps worth filling for anyone watching and wondering whether they need to switch too.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

Nikki Ryan | 40+ Style & Glow Up · Instagram creator

77.8K views on this video

HRT/PERIMENOPAUSE. I have gone to share this a few times then quickly clicked cancel. I don’t really know why?! It’s a personal thing, but so many are struggling right now with this too, so I’m sharin

Frequently asked questions

Quick answers based on this video and our medical team review.

What does the video say about oral progesterone undergoes first-pass liver metabolism producing neuroactive steroids,?

Oral progesterone undergoes first-pass liver metabolism producing neuroactive steroids, which cause bloating, sedation, and mood changes in a clinically significant subset of women (Stanczyk et al., 2015, Climacteric).

What does the video say about the mirena iud delivers levonorgestrel locally to the uterine lining?

The Mirena IUD delivers levonorgestrel locally to the uterine lining with very low systemic absorption, making it a lower-side-effect alternative progestogen for women on systemic estrogen HRT.

What does the video say about hamoda et al. (2022, post reproductive health) confirmed mirena provides?

Hamoda et al. (2022, Post Reproductive Health) confirmed Mirena provides effective endometrial protection for up to five years when combined with systemic estrogen therapy.

What does the video say about the mirena?

The Mirena is used off-label as a progestogen in HRT in many countries, including the UK, meaning it is not specifically licensed for this purpose, though it is recognized in British Menopause Society guidance.

What does the video say about timing?

Timing oral progesterone at night with food can reduce side effects for some women before a full switch to another delivery method is considered.

What does the video say about transdermal progesterone cream?

Transdermal progesterone cream is another alternative but has weaker evidence for endometrial protection compared to the Mirena or oral progesterone.

Sources & references

Citations extracted from our medical team's review. Click any citation to search PubMed.

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Read More on This Topic

Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.

Not medical advice. This video was made by Nikki Ryan | 40+ Style & Glow Up, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.